rs121908610
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PM2PP3_ModeratePP5_Very_Strong
The NM_004820.5(CYP7B1):c.1088C>T(p.Ser363Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000335 in 1,614,018 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_004820.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CYP7B1 | NM_004820.5 | c.1088C>T | p.Ser363Phe | missense_variant | Exon 5 of 6 | ENST00000310193.4 | NP_004811.1 | |
CYP7B1 | NM_001324112.2 | c.1088C>T | p.Ser363Phe | missense_variant | Exon 5 of 7 | NP_001311041.1 | ||
CYP7B1 | XM_017014002.2 | c.1154C>T | p.Ser385Phe | missense_variant | Exon 6 of 7 | XP_016869491.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152188Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000796 AC: 2AN: 251244Hom.: 0 AF XY: 0.0000147 AC XY: 2AN XY: 135776
GnomAD4 exome AF: 0.0000363 AC: 53AN: 1461830Hom.: 0 Cov.: 32 AF XY: 0.0000413 AC XY: 30AN XY: 727218
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152188Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74342
ClinVar
Submissions by phenotype
Hereditary spastic paraplegia Pathogenic:2
This missense variant results in a change from serine to phenylalanine at amino acid position 363. It has been previously reported in a homozygous state in one consanguineous family affected with spastic paraplegia and this variant was found to segregate with disease state in this family (PMID: 18252231). Mutational analysis predicts this variant to impact phosphorylation and ligand binding (Siam et al. (2012) PMID: 21541746). In silico prediction programs gave conflicting with regards to the impact of this variant on protein function. This variant is observed at an allele frequency of 0.00080% in population controls of the Genome Aggregation Database (gnomAD). Based on the evidence above, this variant is classified as likely pathogenic (PP1_S, PM2, PM3_P). -
Variant summary: CYP7B1 c.1088C>T (p.Ser363Phe) results in a non-conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 8e-06 in 251244 control chromosomes. c.1088C>T has been reported in the literature in multiple individuals from one consanguineous family affected with features of Hereditary Spastic Paraplegia, Type 5a that was identified by linkage analysis (example, Tsaousidou_2008, cited by Chou_2020, Schols_2017). These data indicate that the variant is very likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. One clinical diagnostic laboratory has submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation and classified the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as likely pathogenic. -
Spastic paraplegia Pathogenic:1
This sequence change replaces serine, which is neutral and polar, with phenylalanine, which is neutral and non-polar, at codon 363 of the CYP7B1 protein (p.Ser363Phe). This variant is present in population databases (rs121908610, gnomAD 0.0009%). This missense change has been observed in individual(s) with hereditary spastic paraplegia (PMID: 18252231). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 6101). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt CYP7B1 protein function with a positive predictive value of 95%. For these reasons, this variant has been classified as Pathogenic. -
Hereditary spastic paraplegia 5A Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at